| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9ccf08007698b81564d52e1ad490d4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebf8863c06fa897b8e443c10a17b1828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b8be459b24eaabc1071fedab552566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20d6b22fb0aeb6cf3d4e8ba9c3faf5ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7affc6f386238b5ec5fc7d0a53f0b625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55ebec974aebf5dd83ecc73c4b0ab741 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-23 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1232 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 |
| filingDate |
2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_203be0a464f4ab6b2e3037b30511f026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffcee93a0f1afc5522d71f8e4a754813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_892ce912aa69b221a48fac5bfac59aaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa5fc977e86f72e3148aa5140ef2c575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a61059405f56c4fb808713e18bc5851 |
| publicationDate |
2014-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8623372-B2 |
| titleOfInvention |
Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
| abstract |
The present invention relates to antibodies immunologically specific for an attaching and effacing Escherichia coli (AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa. |
| priorityDate |
2001-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |